Suppr超能文献

提高植物毒性研究的严谨性和实用性:推荐资源。

Improving the rigor and utility of botanical toxicity studies: Recommended resources.

机构信息

Amway Corporation, Buena Park, California, USA.

Office of Dietary Supplements, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.

出版信息

Regul Toxicol Pharmacol. 2023 Oct;144:105471. doi: 10.1016/j.yrtph.2023.105471. Epub 2023 Aug 19.

Abstract

Interest in botanicals, particularly as dietary supplement ingredients, is growing steadily. This growth, and the marketing of new ingredients and combination products as botanical dietary supplements, underscores the public health need for a better understanding of potential toxicities associated with use of these products. This article and accompanying template outline the resources to collect literature and relevant information to support the design of botanical toxicity studies. These resources provide critical information related to botanical identification, characterization, pre-clinical and clinical data, including adverse effects and interactions with pharmaceuticals. Toxicologists using these resources should collaborate with pharmacognosists and/or analytical chemists to enhance knowledge of the botanical material being tested. Overall, this guide and resource list is meant to help locate relevant information that can be leveraged to inform on decisions related to toxicity testing of botanicals, including the design of higher quality toxicological studies.

摘要

人们对植物药的兴趣与日俱增,尤其是将其作为膳食补充剂的成分。这种增长,以及新成分和组合产品作为植物药膳食补充剂的营销,凸显了公众对更好地了解使用这些产品相关潜在毒性的需求。本文和附带的模板概述了收集文献和相关信息的资源,以支持植物毒性研究的设计。这些资源提供了与植物鉴定、特征描述、临床前和临床数据相关的关键信息,包括不良反应和与药物的相互作用。毒理学家使用这些资源时,应与生药学专家和/或分析化学家合作,以增强对正在测试的植物材料的了解。总的来说,本指南和资源清单旨在帮助找到相关信息,以便为植物毒性测试的决策提供信息,包括更高质量毒理学研究的设计。

相似文献

1
Improving the rigor and utility of botanical toxicity studies: Recommended resources.
Regul Toxicol Pharmacol. 2023 Oct;144:105471. doi: 10.1016/j.yrtph.2023.105471. Epub 2023 Aug 19.
2
Risk assessment of botanicals and botanical preparations intended for use in food and food supplements: emerging issues.
Toxicol Lett. 2008 Aug 15;180(2):131-6. doi: 10.1016/j.toxlet.2008.05.024. Epub 2008 Jun 17.
4
The Botanical Safety Consortium: A public-private partnership to enhance the botanical safety toolkit.
Regul Toxicol Pharmacol. 2022 Feb;128:105090. doi: 10.1016/j.yrtph.2021.105090. Epub 2021 Dec 1.
5
In silico approach to safety of botanical dietary supplement ingredients utilizing constituent-level characterization.
Food Chem Toxicol. 2017 Sep;107(Pt A):418-429. doi: 10.1016/j.fct.2017.07.017. Epub 2017 Jul 8.
6
Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment.
Food Chem Toxicol. 2018 Aug;118:963-971. doi: 10.1016/j.fct.2018.04.007. Epub 2018 Apr 4.
7
Finding the bad actor: Challenges in identifying toxic constituents in botanical dietary supplements.
Food Chem Toxicol. 2019 Feb;124:431-438. doi: 10.1016/j.fct.2018.12.026. Epub 2018 Dec 21.
8
Recent studies on selected botanical dietary supplement ingredients.
Anal Bioanal Chem. 2007 Sep;389(1):27-35. doi: 10.1007/s00216-007-1254-7. Epub 2007 Mar 28.
9
Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals.
J Diet Suppl. 2025;22(1):162-192. doi: 10.1080/19390211.2024.2417679. Epub 2024 Oct 25.
10

引用本文的文献

1
Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium.
Regul Toxicol Pharmacol. 2024 Nov;153:105708. doi: 10.1016/j.yrtph.2024.105708. Epub 2024 Sep 19.
2
Chemical Standardization of Milk Thistle ( L.) Extract Using UHPLC-MS/MS and the Method of Standard Addition.
J Am Soc Mass Spectrom. 2024 Aug 7;35(8):1726-1732. doi: 10.1021/jasms.4c00125. Epub 2024 Jul 2.
3
Advancing botanical safety: A strategy for selecting, sourcing, and characterizing botanicals for developing toxicological tools.
Food Chem Toxicol. 2024 Apr;186:114537. doi: 10.1016/j.fct.2024.114537. Epub 2024 Feb 27.

本文引用的文献

1
Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
JAMA. 2022 Dec 13;328(22):2252-2264. doi: 10.1001/jama.2022.21022.
2
Understanding plant to extract ratios in botanical extracts.
Front Pharmacol. 2022 Sep 30;13:981978. doi: 10.3389/fphar.2022.981978. eCollection 2022.
4
The Botanical Safety Consortium: A public-private partnership to enhance the botanical safety toolkit.
Regul Toxicol Pharmacol. 2022 Feb;128:105090. doi: 10.1016/j.yrtph.2021.105090. Epub 2021 Dec 1.
6
"Natural" is not synonymous with "Safe": Toxicity of natural products alone and in combination with pharmaceutical agents.
Regul Toxicol Pharmacol. 2020 Jun;113:104642. doi: 10.1016/j.yrtph.2020.104642. Epub 2020 Mar 18.
7
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.
Toxicol Rep. 2020 Feb 15;7:386-402. doi: 10.1016/j.toxrep.2020.02.008. eCollection 2020.
8
Improving natural product research translation: From source to clinical trial.
FASEB J. 2020 Jan;34(1):41-65. doi: 10.1096/fj.201902143R. Epub 2019 Dec 10.
9
Clinical relevance of St. John's wort drug interactions revisited.
Br J Pharmacol. 2020 Mar;177(6):1212-1226. doi: 10.1111/bph.14936. Epub 2020 Jan 17.
10
The Dietary Supplement Label Database: Recent Developments and Applications.
J Nutr. 2018 Aug;148(Suppl 2):1428S-1435S. doi: 10.1093/jn/nxy082. Epub 2018 Aug 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验